Dr. Hc Willy Michel
Chairman of the Board of Directors of Ypsomed Hold
Management and Administration
YPSO MED Self Care Solutions
Switzerland
Biography
Willy Michel was Chairman of the Board of Directors and CEO of Disetronic Holding AG until April 2003 and has been Chairman of the Board of Directors of Ypsomed Holding AG since 2003. From August 2011 to June 2014 Willy Michel was the delegate of the Board of Directors and CEO of Ypsomed Holding AG and the Ypsomed Group. He founded the Disetronic with his brother in 1984 and co-operated with him until his retirement in 1995, and then he was solely responsible for the development, production, sales and sale of Disetronic products (until 1999). As part of the sale of Disetronic to Roche Holding AG in 2003, Willy Michel bought back the injection area of ​​Disetronic, which now operates under Ypsomed. Before founding the Disetronic, Willy Michel, who had a professional degree as a Swiss citizen, Dipl. He holds six years of leadership at Novo Nordisk Schweiz (from 1978 to 1984) for six years. Willy Michel was the founder, majority owner and president of the Board of Directors of the Finox AG, which is sold to Gedeon Richter in 2016, which is aimed at the development, manufacture and distribution of medicines. Willy Michel is a majority shareholder and Chairman of the Board of Directors of Fertility Biotech AG, who was founded in 2016, Vice Chairman of the Board of BV Holding AG, listed on the BX Berne eXchange AG (2001-2008 2008) 2007) of the Board of Directors of the Adval Tech Holding AG listed on the SIX Swiss Exchange. He is also the owner of several companies, including well-known companies in the art sector, watchmaking and gastronomy, and serves as a board of directors of various non-listed, Willy Michel was awarded the "Master Entrepreneur of the Year" by Ernst & Young AG in 2005 and the Honorary Doctor (Dr. hc) from the Faculty of Economics and Social Sciences at the University of Bern in 2006. The Swiss Association for Internal and Integrated Communication (SVIK) awarded the "Communicator of the Year" (COTY) Award 2014 in 2014.
Research Interest
Has a research interest in Medicine and Clinical Trials Sector
